Publications
2 shownMaintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
The use of maintenance therapy with olaparib provided a substantial benefit with regard to progression-free survival among women with newly diagnosed advanced ovarian cancer and...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,872
- Institution
- AstraZeneca (United Kingdom)
External Links
Identifiers
- ORCID
- 0000-0003-3573-7208
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.